Sort
48,018 grants matching “immunotherapy”
Mechanisms Underlying Clearance of Persistent Infections
$2,426,970Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Mechanisms Underlying Clearance of Persistent Infections and Tumors
$2,426,970Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
Growth Factor Imaging and Photoimmunotherapy
$2,426,730Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
$2,425,687Song Yao · Roswell Park Cancer Institute Corp · UH3 · FY2025 · CA
Vaccine Induced Immunity in the Young and Aged
$2,425,378Rafi Ahmed · Emory University · U19 · FY2019 · AI
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$2,424,537Rachel R. Caspi · National Eye Institute · ZIA · FY2014 · EY
Spore in Head and Neck Cancer
$2,424,440David Sidransky · Johns Hopkins University · P50 · FY2012 · DE
Brain Tumor SPORE Grant
$2,423,837Mitchel S. Berger · University Of California, San Francisco · P50 · FY2025 · CA
Pacific Ovarian Cancer Research Consoritum
$2,422,562Nicole D. Urban · Fred Hutchinson Cancer Research Center · P50 · FY2006 · CA
Implantable Nanophotonic Sensors for in Vivo Immunoresponse
$2,422,500Mekhail Anwar · University Of California, San Francisco · DP2 · FY2020 · DE
Cancer Center Support Grant (CCSG)
$2,421,963George J Weiner · University Of Iowa · P30 · FY2015 · CA
Engineering T cells to Provide Durable Control of HIV-1 Replication
$2,421,905James L Riley · University Of Pennsylvania · U19 · FY2023 · AI
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
$2,421,788Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2021 · CA
Epigenetic Therapies - New Approaches
$2,421,039Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2024 · CA
Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer
$2,420,487George J Weiner · University Of Iowa · P50 · FY2020 · CA
Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
$2,420,381Paul M. Lieberman · Wistar Institute · P01 · FY2025 · CA
SPORE in Head and Neck Cancer
$2,419,163University Of Pittsburgh At Pittsburgh · P50 · FY2005 · CA
Human anti-viral immune responses in tissues and circulation
$2,417,900Donna L Farber · Columbia University Health Sciences · U19 · FY2019 · AI
Engineering the Next-generation of Custom Immune Cell Therapies
$2,415,750Kole T Roybal · University Of California, San Francisco · DP2 · FY2018 · CA
STEM CELL TRANSPLANTATION FOR TX OF AUTOIMMUNE DISEASES
$2,413,890Northwestern University · N01 · FY2000 · AI
SPORE in Ovarian Cancer
$2,412,603Fox Chase Cancer Center · P50 · FY2005 · CA
SPORE in Cervical Cancer
$2,412,090T.-C. Wu · Johns Hopkins University · P50 · FY2007 · CA
Adoptive Cell Transfer Immunotherapy of Cancer
$2,411,384Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Gene therapy of cancer
$2,411,384Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Cancer Center Support Grant
$2,410,577Michael J Weber · University Of Virginia · P30 · FY2010 · CA